1 Study Coverage
    1.1 Veterinary Infectious Diseases Therapeutics Product Introduction
    1.2 Market by Type
        1.2.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Antibiotics
        1.2.3 Antiviral
        1.2.4 Antifungal
        1.2.5 Amebicides
        1.2.6 Anthelmintics
    1.3 Market by Application
        1.3.1 Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Swine
        1.3.3 Chicken
        1.3.4 Dog
        1.3.5 Cat
        1.3.6 Cow
        1.3.7 Horse
        1.3.8 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Veterinary Infectious Diseases Therapeutics Sales Estimates and Forecasts 2017-2028
    2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Estimates and Forecasts 2017-2028
    2.3 Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Veterinary Infectious Diseases Therapeutics Sales by Region
        2.4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2022)
        2.4.2 Global Sales Veterinary Infectious Diseases Therapeutics by Region (2023-2028)
    2.5 Global Veterinary Infectious Diseases Therapeutics Revenue by Region
        2.5.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2022)
        2.5.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers
        3.1.1 Global Top Veterinary Infectious Diseases Therapeutics Manufacturers by Sales (2017-2022)
        3.1.2 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Infectious Diseases Therapeutics in 2021
    3.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers
        3.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2017-2022)
        3.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Veterinary Infectious Diseases Therapeutics Revenue in 2021
    3.3 Global Veterinary Infectious Diseases Therapeutics Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Veterinary Infectious Diseases Therapeutics Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Veterinary Infectious Diseases Therapeutics Sales by Type
        4.1.1 Global Veterinary Infectious Diseases Therapeutics Historical Sales by Type (2017-2022)
        4.1.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Sales by Type (2023-2028)
        4.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
    4.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Type
        4.2.1 Global Veterinary Infectious Diseases Therapeutics Historical Revenue by Type (2017-2022)
        4.2.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
    4.3 Global Veterinary Infectious Diseases Therapeutics Price by Type
        4.3.1 Global Veterinary Infectious Diseases Therapeutics Price by Type (2017-2022)
        4.3.2 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Veterinary Infectious Diseases Therapeutics Sales by Application
        5.1.1 Global Veterinary Infectious Diseases Therapeutics Historical Sales by Application (2017-2022)
        5.1.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Sales by Application (2023-2028)
        5.1.3 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
    5.2 Global Veterinary Infectious Diseases Therapeutics Revenue by Application
        5.2.1 Global Veterinary Infectious Diseases Therapeutics Historical Revenue by Application (2017-2022)
        5.2.2 Global Veterinary Infectious Diseases Therapeutics Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
    5.3 Global Veterinary Infectious Diseases Therapeutics Price by Application
        5.3.1 Global Veterinary Infectious Diseases Therapeutics Price by Application (2017-2022)
        5.3.2 Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Veterinary Infectious Diseases Therapeutics Market Size by Type
        6.1.1 North America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
        6.1.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
    6.2 North America Veterinary Infectious Diseases Therapeutics Market Size by Application
        6.2.1 North America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
        6.2.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
    6.3 North America Veterinary Infectious Diseases Therapeutics Market Size by Country
        6.3.1 North America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
        6.3.2 North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Veterinary Infectious Diseases Therapeutics Market Size by Type
        7.1.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
        7.1.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
    7.2 Europe Veterinary Infectious Diseases Therapeutics Market Size by Application
        7.2.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
        7.2.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
    7.3 Europe Veterinary Infectious Diseases Therapeutics Market Size by Country
        7.3.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
        7.3.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Size by Type
        8.1.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
        8.1.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
    8.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Size by Application
        8.2.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
        8.2.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
    8.3 Asia Pacific Veterinary Infectious Diseases Therapeutics Market Size by Region
        8.3.1 Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2028)
        8.3.2 Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Veterinary Infectious Diseases Therapeutics Market Size by Type
        9.1.1 Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
        9.1.2 Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
    9.2 Latin America Veterinary Infectious Diseases Therapeutics Market Size by Application
        9.2.1 Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
        9.2.2 Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
    9.3 Latin America Veterinary Infectious Diseases Therapeutics Market Size by Country
        9.3.1 Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
        9.3.2 Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Size by Type
        10.1.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2028)
    10.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Size by Application
        10.2.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2028)
    10.3 Middle East and Africa Veterinary Infectious Diseases Therapeutics Market Size by Country
        10.3.1 Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Elanco Animal Health
        11.1.1 Elanco Animal Health Corporation Information
        11.1.2 Elanco Animal Health Overview
        11.1.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Elanco Animal Health Recent Developments
    11.2 Novartis Animal Health
        11.2.1 Novartis Animal Health Corporation Information
        11.2.2 Novartis Animal Health Overview
        11.2.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Novartis Animal Health Recent Developments
    11.3 Merck
        11.3.1 Merck Corporation Information
        11.3.2 Merck Overview
        11.3.3 Merck Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Merck Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Merck Recent Developments
    11.4 Pfizer Animal Health
        11.4.1 Pfizer Animal Health Corporation Information
        11.4.2 Pfizer Animal Health Overview
        11.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Pfizer Animal Health Recent Developments
    11.5 Sanofi
        11.5.1 Sanofi Corporation Information
        11.5.2 Sanofi Overview
        11.5.3 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Sanofi Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Sanofi Recent Developments
    11.6 Boehringer Ingelheim Vetmedica
        11.6.1 Boehringer Ingelheim Vetmedica Corporation Information
        11.6.2 Boehringer Ingelheim Vetmedica Overview
        11.6.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Boehringer Ingelheim Vetmedica Recent Developments
    11.7 Dechra Animal Health
        11.7.1 Dechra Animal Health Corporation Information
        11.7.2 Dechra Animal Health Overview
        11.7.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Dechra Animal Health Recent Developments
    11.8 Ceva Sante Animale
        11.8.1 Ceva Sante Animale Corporation Information
        11.8.2 Ceva Sante Animale Overview
        11.8.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Ceva Sante Animale Recent Developments
    11.9 Elanco Animal Health
        11.9.1 Elanco Animal Health Corporation Information
        11.9.2 Elanco Animal Health Overview
        11.9.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Elanco Animal Health Recent Developments
    11.10 Virbac
        11.10.1 Virbac Corporation Information
        11.10.2 Virbac Overview
        11.10.3 Virbac Veterinary Infectious Diseases Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Virbac Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Virbac Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Veterinary Infectious Diseases Therapeutics Industry Chain Analysis
    12.2 Veterinary Infectious Diseases Therapeutics Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Veterinary Infectious Diseases Therapeutics Production Mode & Process
    12.4 Veterinary Infectious Diseases Therapeutics Sales and Marketing
        12.4.1 Veterinary Infectious Diseases Therapeutics Sales Channels
        12.4.2 Veterinary Infectious Diseases Therapeutics Distributors
    12.5 Veterinary Infectious Diseases Therapeutics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Veterinary Infectious Diseases Therapeutics Industry Trends
    13.2 Veterinary Infectious Diseases Therapeutics Market Drivers
    13.3 Veterinary Infectious Diseases Therapeutics Market Challenges
    13.4 Veterinary Infectious Diseases Therapeutics Market Restraints
14 Key Findings in The Global Veterinary Infectious Diseases Therapeutics Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Antibiotics
    Table 3. Major Manufacturers of Antiviral
    Table 4. Major Manufacturers of Antifungal
    Table 5. Major Manufacturers of Amebicides
    Table 6. Major Manufacturers of Anthelmintics
    Table 7. Global Veterinary Infectious Diseases Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Veterinary Infectious Diseases Therapeutics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2022) & (KG)
    Table 10. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2017-2022)
    Table 11. Global Veterinary Infectious Diseases Therapeutics Sales by Region (2023-2028) & (KG)
    Table 12. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2023-2028)
    Table 13. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2017-2022)
    Table 15. Global Veterinary Infectious Diseases Therapeutics Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2023-2028)
    Table 17. Global Veterinary Infectious Diseases Therapeutics Sales by Manufacturers (2017-2022) & (KG)
    Table 18. Global Veterinary Infectious Diseases Therapeutics Sales Share by Manufacturers (2017-2022)
    Table 19. Global Veterinary Infectious Diseases Therapeutics Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Manufacturers (2017-2022)
    Table 21. Veterinary Infectious Diseases Therapeutics Price by Manufacturers (2017-2022) &(USD/KG)
    Table 22. Global Veterinary Infectious Diseases Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Veterinary Infectious Diseases Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Infectious Diseases Therapeutics as of 2021)
    Table 24. Veterinary Infectious Diseases Therapeutics Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Veterinary Infectious Diseases Therapeutics Product Offered
    Table 26. Date of Manufacturers Enter into Veterinary Infectious Diseases Therapeutics Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
    Table 29. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
    Table 30. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2017-2022)
    Table 31. Global Veterinary Infectious Diseases Therapeutics Sales Share by Type (2023-2028)
    Table 32. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2017-2022)
    Table 35. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Type (2023-2028)
    Table 36. Veterinary Infectious Diseases Therapeutics Price by Type (2017-2022) & (USD/KG)
    Table 37. Global Veterinary Infectious Diseases Therapeutics Price Forecast by Type (2023-2028) & (USD/KG)
    Table 38. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
    Table 39. Global Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
    Table 40. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2017-2022)
    Table 41. Global Veterinary Infectious Diseases Therapeutics Sales Share by Application (2023-2028)
    Table 42. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2017-2022)
    Table 45. Global Veterinary Infectious Diseases Therapeutics Revenue Share by Application (2023-2028)
    Table 46. Veterinary Infectious Diseases Therapeutics Price by Application (2017-2022) & (USD/KG)
    Table 47. Global Veterinary Infectious Diseases Therapeutics Price Forecast by Application (2023-2028) & (USD/KG)
    Table 48. North America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
    Table 49. North America Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
    Table 50. North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
    Table 53. North America Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
    Table 54. North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
    Table 57. North America Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
    Table 58. North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
    Table 61. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
    Table 62. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
    Table 65. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
    Table 66. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
    Table 69. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
    Table 70. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
    Table 73. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
    Table 74. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
    Table 77. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
    Table 78. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2017-2022) & (KG)
    Table 81. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales by Region (2023-2028) & (KG)
    Table 82. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
    Table 85. Latin America Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
    Table 86. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
    Table 89. Latin America Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
    Table 90. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
    Table 93. Latin America Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
    Table 94. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2017-2022) & (KG)
    Table 97. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2023-2028) & (KG)
    Table 98. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2017-2022) & (KG)
    Table 101. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2023-2028) & (KG)
    Table 102. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2017-2022) & (KG)
    Table 105. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2023-2028) & (KG)
    Table 106. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Elanco Animal Health Corporation Information
    Table 109. Elanco Animal Health Description and Major Businesses
    Table 110. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
    Table 111. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Elanco Animal Health Recent Developments
    Table 113. Novartis Animal Health Corporation Information
    Table 114. Novartis Animal Health Description and Major Businesses
    Table 115. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
    Table 116. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Novartis Animal Health Recent Developments
    Table 118. Merck Corporation Information
    Table 119. Merck Description and Major Businesses
    Table 120. Merck Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
    Table 121. Merck Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Merck Recent Developments
    Table 123. Pfizer Animal Health Corporation Information
    Table 124. Pfizer Animal Health Description and Major Businesses
    Table 125. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
    Table 126. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Pfizer Animal Health Recent Developments
    Table 128. Sanofi Corporation Information
    Table 129. Sanofi Description and Major Businesses
    Table 130. Sanofi Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
    Table 131. Sanofi Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Sanofi Recent Developments
    Table 133. Boehringer Ingelheim Vetmedica Corporation Information
    Table 134. Boehringer Ingelheim Vetmedica Description and Major Businesses
    Table 135. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
    Table 136. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Boehringer Ingelheim Vetmedica Recent Developments
    Table 138. Dechra Animal Health Corporation Information
    Table 139. Dechra Animal Health Description and Major Businesses
    Table 140. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
    Table 141. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Dechra Animal Health Recent Developments
    Table 143. Ceva Sante Animale Corporation Information
    Table 144. Ceva Sante Animale Description and Major Businesses
    Table 145. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
    Table 146. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Ceva Sante Animale Recent Developments
    Table 148. Elanco Animal Health Corporation Information
    Table 149. Elanco Animal Health Description and Major Businesses
    Table 150. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
    Table 151. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Elanco Animal Health Recent Developments
    Table 153. Virbac Corporation Information
    Table 154. Virbac Description and Major Businesses
    Table 155. Virbac Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2017-2022)
    Table 156. Virbac Veterinary Infectious Diseases Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Virbac Recent Developments
    Table 158. Key Raw Materials Lists
    Table 159. Raw Materials Key Suppliers Lists
    Table 160. Veterinary Infectious Diseases Therapeutics Distributors List
    Table 161. Veterinary Infectious Diseases Therapeutics Customers List
    Table 162. Veterinary Infectious Diseases Therapeutics Market Trends
    Table 163. Veterinary Infectious Diseases Therapeutics Market Drivers
    Table 164. Veterinary Infectious Diseases Therapeutics Market Challenges
    Table 165. Veterinary Infectious Diseases Therapeutics Market Restraints
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Veterinary Infectious Diseases Therapeutics Product Picture
    Figure 3. Global Veterinary Infectious Diseases Therapeutics Market Share by Type in 2021 & 2028
    Figure 3. Antibiotics Product Picture
    Figure 4. Antiviral Product Picture
    Figure 5. Antifungal Product Picture
    Figure 6. Amebicides Product Picture
    Figure 7. Anthelmintics Product Picture
    Figure 8. Global Veterinary Infectious Diseases Therapeutics Market Share by Application in 2021 & 2028
    Figure 9. Swine
    Figure 10. Chicken
    Figure 11. Dog
    Figure 12. Cat
    Figure 13. Cow
    Figure 14. Horse
    Figure 15. Other
    Figure 16. Veterinary Infectious Diseases Therapeutics Report Years Considered
    Figure 17. Global Veterinary Infectious Diseases Therapeutics Sales 2017-2028 (KG)
    Figure 18. Global Veterinary Infectious Diseases Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 19. Global Veterinary Infectious Diseases Therapeutics Revenue 2017-2028 (US$ Million)
    Figure 20. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 21. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2017-2022)
    Figure 22. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2023-2028)
    Figure 23. North America Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
    Figure 24. North America Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
    Figure 26. Europe Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
    Figure 28. Asia-Pacific Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Latin America Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
    Figure 30. Latin America Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales YoY (2017-2028) & (KG)
    Figure 32. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 33. The Veterinary Infectious Diseases Therapeutics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 34. The Top 5 and 10 Largest Manufacturers of Veterinary Infectious Diseases Therapeutics in the World: Market Share by Veterinary Infectious Diseases Therapeutics Revenue in 2021
    Figure 35. Global Veterinary Infectious Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 36. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
    Figure 37. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 38. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
    Figure 39. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 40. North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
    Figure 41. North America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 42. North America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
    Figure 43. North America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 44. North America Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
    Figure 45. North America Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
    Figure 46. U.S. Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 47. Canada Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 48. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
    Figure 49. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 50. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
    Figure 51. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 52. Europe Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
    Figure 53. Europe Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
    Figure 54. Germany Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 55. France Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 56. U.K. Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 57. Italy Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 58. Russia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 59. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 61. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 63. Asia Pacific Veterinary Infectious Diseases Therapeutics Sales Share by Region (2017-2028)
    Figure 64. Asia Pacific Veterinary Infectious Diseases Therapeutics Revenue Share by Region (2017-2028)
    Figure 65. China Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 66. Japan Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 67. South Korea Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 68. India Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 69. Australia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 70. Taiwan Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 71. Indonesia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 72. Thailand Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 73. Malaysia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 74. Philippines Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 75. Latin America Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
    Figure 76. Latin America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 77. Latin America Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
    Figure 78. Latin America Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 79. Latin America Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
    Figure 80. Latin America Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
    Figure 81. Mexico Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 82. Brazil Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 83. Argentina Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 84. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 86. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 88. Middle East and Africa Veterinary Infectious Diseases Therapeutics Sales Share by Country (2017-2028)
    Figure 89. Middle East and Africa Veterinary Infectious Diseases Therapeutics Revenue Share by Country (2017-2028)
    Figure 90. Turkey Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 91. Saudi Arabia Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 92. U.A.E Veterinary Infectious Diseases Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 93. Veterinary Infectious Diseases Therapeutics Value Chain
    Figure 94. Veterinary Infectious Diseases Therapeutics Production Process
    Figure 95. Channels of Distribution
    Figure 96. Distributors Profiles
    Figure 97. Bottom-up and Top-down Approaches for This Report
    Figure 98. Data Triangulation
    Figure 99. Key Executives Interviewed